Concepedia

Publication | Open Access

Cediranib inhibits both the intraosseous growth of PDGF D‐Positive prostate cancer cells and the associated bone reaction

DOIFull Paper Access

25

Citations

40

References

2011

Year

Abdo J. Najy, Young Suk Jung, Joshua J. Won, M. Katie Conley‐LaComb, Allen Saliganan, Chong Jai Kim, Elisabeth I. Heath, Michael L. Cher, R. Daniel Bonfil, Hyeong‐Reh Choi Kim
The Prostate

Abstract

These novel findings support the utilization of cediranib, either alone or in combination with docetaxel, to treat bone metastatic PCa exhibiting PDGF D expression.

References

YearCitations

Page 1